Data / Form D filings / inSoma Bio, Inc.
inSoma Bio, Inc.: Form D filings
inSoma Bio, Inc., a biotechnology company in Durham, NC, filed 12 Form D notices with the SEC between 2020 and 2026. The latest, on January 22, 2026, reports $2.7 million sold of a $4 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 701 W. MAIN STREET, SUITE 410, Durham, NC, 27701
- Phone
- (901) 827-4757
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1814250
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | Amendment | $4,000,000 | $2,689,372 | $1,310,628 | 15 | Sep 24, 2025 | sec.gov |
| Oct 20, 2025 | New notice | $3,000,000 | $1,925,572 | $1,074,428 | 8 | Sep 24, 2025 | sec.gov |
| May 6, 2024 | Amendment | $3,000,000 | $2,720,749 | $279,251 | 16 | Apr 17, 2023 | sec.gov |
| Jun 29, 2023 | Amendment | $3,000,000 | $2,114,547 | $885,453 | 9 | Apr 17, 2023 | sec.gov |
| May 1, 2023 | New notice | $3,000,000 | $1,105,000 | $1,895,000 | 3 | Apr 17, 2023 | sec.gov |
| Dec 1, 2020 | Amendment | $1,500,000 | $1,273,675 | $226,325 | 31 | Aug 20, 2020 | sec.gov |
| Nov 9, 2020 | Amendment | $1,500,000 | $1,180,000 | $320,000 | 29 | Aug 20, 2020 | sec.gov |
| Oct 26, 2020 | Amendment | $1,000,000 | $385,000 | $615,000 | 8 | Aug 20, 2020 | sec.gov |
| Oct 13, 2020 | Amendment | $1,000,000 | $310,000 | $690,000 | 5 | Aug 20, 2020 | sec.gov |
| Sep 17, 2020 | Amendment | $1,000,000 | $110,000 | $890,000 | 4 | Aug 20, 2020 | sec.gov |
| Sep 3, 2020 | New notice | $1,000,000 | $50,000 | $950,000 | 1 | Aug 20, 2020 | sec.gov |
| Jul 9, 2020 | New notice | $202,000 | $202,000 | 7 | Jun 24, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stefan Roberts | Executive Officer, Director | |
| Ashutosh Chilkoti | Executive Officer, Director | |
| Juliana Blum | Director | |
| Heather Brennan | Director | |
| June S. Almenoff | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Jan 19, 2026 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what inSoma Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.